Cargando…
Age-Related Low Bone Mineral Density in C57BL/6 Mice Is Reflective of Aberrant Bone Morphogenetic Protein-2 Signaling Observed in Human Patients Diagnosed with Osteoporosis
Osteoporosis (OP) is a bone disorder characterized by decreased bone mineral density (BMD). Bone Morphogenetic Protein-2 (BMP-2) injections are used to promote bone formation in OP patients. However, patients are unresponsive to BMP-2 while displaying an upregulation of BMP Receptor Type 1a (BMPRIa)...
Autores principales: | Halloran, Daniel, Pandit, Venu, MacMurray, Connor, Stone, Victoria, DeGeorge, Kailey, Eskander, Mark, Root, Denise, McTague, Sean, Pelkey, Heather, Nohe, Anja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570292/ https://www.ncbi.nlm.nih.gov/pubmed/36232525 http://dx.doi.org/10.3390/ijms231911205 |
Ejemplares similares
-
Aberrant BMP2 Signaling in Patients Diagnosed with Osteoporosis
por: Durbano, Hilary W., et al.
Publicado: (2020) -
Differentiation of Cells Isolated from Human Femoral Heads into Functional Osteoclasts
por: Halloran, Daniel R., et al.
Publicado: (2022) -
Bone Morphogenetic Protein-2 in Development and Bone Homeostasis
por: Halloran, Daniel, et al.
Publicado: (2020) -
Bone Morphogenetic Protein-2 Conjugated to Quantum Dot(®)s is Biologically Functional
por: Halloran, Daniel, et al.
Publicado: (2020) -
The Role of Protein Kinase CK2 in Development and Disease Progression: A Critical Review
por: Halloran, Daniel, et al.
Publicado: (2022)